Catherine A. Sohn Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Catherine A. Sohn.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Catherine A. Sohn. Catherine A. Sohn is a in LANDEC CORP \CA\ ($LNDC) and a Director in LANDEC CORP \CA\ ($LNDC) and a Director in Jazz Pharmaceuticals plc ($JAZZ) and a Director in Neuralstem, Inc. ($CUR) and a Director in Axcella Health Inc. ($AXLA) and a Director in Rubius Therapeutics, Inc. ($RUBY).

Address: C/O JAZZ PHARMACEUTICALS PLC 45 FITZWILLIAM SQUARE DUBLIN 2 Ireland

Companies in which Catherine A. Sohn is an Insider

Axcella Health Inc.

Trading Symbol: AXLA
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Catherine A. Sohn: Director
Holdings: 1,000 shares
Latest Transaction: May 22 2020

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Jazz Pharmaceuticals plc

Trading Symbol: JAZZ
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Catherine A. Sohn: Director
Holdings: 15,122 shares
Current Value: $1,891,006
Latest Transaction: Nov 06 2020
$JAZZ Market Capitalization: $7.62B
$JAZZ Previous Close: $125.05

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

LANDEC CORP \CA\

Trading Symbol: LNDC
Industry: CANNED, FRUITS, VEG & PRESERVES, JAMS & JELLIES [2033]
Position of Catherine A. Sohn:
Holdings: 47,010 shares
Current Value: $589,976
Latest Transaction: Jun 03 2021
$LNDC Market Capitalization: $346.33M
$LNDC Previous Close: $12.55

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

PALISADE BIO, INC.

Trading Symbol: SNCA
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Catherine A. Sohn: Director
Holdings: 106,952 shares
Current Value: $322,995
Latest Transaction: Jul 06 2015
$SNCA Market Capitalization: $28.01M
$SNCA Previous Close: $3.02

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Rubius Therapeutics, Inc.

Trading Symbol: RUBY
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Catherine A. Sohn: Director
Holdings: 2,500 shares
Latest Transaction: May 13 2021

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of Catherine A. Sohn

Sentiment: All, AXLA, JAZZ, LNDC, SNCA, RUBY

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 03 2021LNDCLANDEC CORP \CA\Sohn Catherine A.Option ExerciseM0.008,30300
Jun 03 2021LNDCLANDEC CORP \CA\Sohn Catherine A.GrantA11.648,30396,64747,01038.7 K to 47 K (+21.45 %)
Jun 03 2021LNDCLANDEC CORP \CA\Sohn Catherine A.Option ExerciseM0.008,30300
Jun 03 2021LNDCLANDEC CORP \CA\Sohn Catherine A.GrantA11.648,30396,64747,01038.7 K to 47 K (+21.45 %)
May 13 2021RUBYRubius Therapeutic ...Sohn Catherine A.DirectorOption ExerciseA23.2525,000581,25025,000
Nov 06 2020JAZZJazz Pharmaceutica ...Sohn Catherine A.DirectorOption ExerciseM81.764,500367,9200
Nov 06 2020JAZZJazz Pharmaceutica ...Sohn Catherine A.DirectorOption ExerciseM46.838,000374,6400

View all Catherine A. Sohn insider transactions.